Jiangsu Aidea Pharmaceutical Co.,Ltd.

Jiangsu Aidea Pharmaceutical Co., Ltd. is a high-tech pharmaceutical company engaged in the development and marketing of a comprehensive portfolio of anti-HIV/AIDS products. Established in 2009 and listed on the Shanghai Stock Exchange STAR Market in 2020, Aidea Pharma utilises its competitive advantages in the research and production of human urine-derived proteins. The company's expertise positions it as a key player in the pharmaceutical industry, focusing on both manufacturing and distribution of innovative medical solutions.

Services include:
- Anatomical Therapeutic Chemical (ATC) Classification
- Development and marketing of anti-HIV/AIDS products
- Research and production of human urine-derived proteins

Jiangsu Aidea Pharmaceutical Co., Ltd. remains committed to advancing pharmaceutical solutions that enhance patient outcomes and contribute to public health. For more information, please visit en.aidea.com.cn.